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ABSTRACT
Background: Studies from several countries have
documented gender disparities in the management of
coronary artery disease. Whether such gender disparities
are seen in Italy and, if so, whether they can be explained
by factors such as age and severity of illness were
investigated.
Methods: 77 974 Piedmontese patients, admitted
between 1999 and 2002, with a primary diagnosis of
myocardial infarction (ICD 410), angina (ICD 413), chronic
ischaemia (ICD 414) and chest pain (ICD 786.5) were
studied. The number of men and women undergoing
surgical treatment was extracted and the male–female
odds ratios calculated. Several risk factors and a risk
adjustment technique (APR-DRG) were used to control for
possible confounders. Backward stepwise multiple logistic
regression was used to adjust for significant covariates.
Results: Crude analysis demonstrated that gender is a
discriminating factor in the probability of surgery (OR 2.11,
95% CI 2.04 to 2.19), with similar findings among those
with each main diagnosis. The odds ratios decreased after
adjustment for age, co-morbidity and disease severity but
remained significant.
Conclusions: Men and women admitted to hospitals in a
region of northern Italy with a diagnosis of cardiovascular
disease are treated differently and this cannot be
explained by age or severity of disease.
Coronary artery disease is the single disorder most
likely to kill women in developed countries.1 2
There is now evidence from several studies,
especially from the USA and the UK3–8 but also
from Japan9 and several continental European
countries10–13 that, compared with men with
cardiovascular disease, women are less likely to
receive interventional cardiac procedures. Yet this
finding is not universal and some researchers have
found no significant gender difference in utilisation
of either medical therapies14–16 or surgical proce-
dures.8 15 17 Where differences have been found,
they have been documented at different stages in
the process of accessing investigation and subse-
quent treatment.18
The contemporary relevance of these findings to
Italy can, however, be questioned. First, given how
the social meaning of gender is influenced by
culture, it cannot be assumed that the phenom-
enon of gender disparity will be found everywhere.
Second, some studies were undertaken when
coronary revascularisation was still a relatively
new procedure and when cardiovascular disease
was still seen as essentially a male disease.19 Indeed,
it has been argued that the modus operandi, both
for investigation and for treatment of this disease,
was developed primarily for men.7 20 It is plausible
that the subsequent expansion of provision could
have redressed the observed gender imbalance, as
has been seen to some extent in Finland.13
The aim of this study was to investigate
whether, in Italy at the beginning of the twenty-
first century, (1) there were gender disparities in
the likelihood of being surgically treated for
coronary artery disease and, if this is the case, (2)
to ascertain the extent to which age, diagnosis,
presence of other risk factors, severity of illness and
risk of mortality may account for these differences.
METHODS
Data on all discharges from every public and
private hospital in the Italian region of Piedmont
between 1 January 1999 and 31 December 2002
were obtained. Piedmont is one of the 20 admin-
istrative regions of Italy and, during those years,
the population of 4 255 456 was 48% men. In the
study period, the hospital network (public and
private) comprised about 90 facilities.
Discharge data are collected routinely on all
patients admitted to any Italian hospital, with
details completed by trained staff (usually physi-
cians or nurses). Each form includes (1) personal
data: name, age, gender, nationality, place of
residence; (2) diagnosis codes (up to six); (3)
procedures undertaken (up to six); (4) length of
stay; and (5) department of admission and
discharge.
Data on diagnosis and procedures are coded
using the International Classification of Disease,
Ninth Revision, Clinical Modification (ICD-9-
CM). Additionally, for each patient admitted in
2000 and in 2002 severity of illness and risk of
mortality were calculated using the 3M APR-DRG
classification system, V12. This proprietary soft-
ware package assigns a value from 0 to 3 to each
patient, corresponding to increasing risk. This score
is generated using data on age and the presence of
co-morbidities, so allowing a meaningful compar-
ison of patients.
Among the 3 320 064 discharge forms collected
between 1999 and 2002, we selected, for each year,
all patients who were admitted with a primary
diagnosis of myocardial infarction (ICD-9-CM
code 410.XX), angina (code 413.X), chronic ischae-
mia (code 414.XX) and chest pain (code 786.5X).
We were interested in the probability of under-
going a first revascularisation; the factors influen-
cing the decision to offer subsequent procedures
may be different. Hence, we excluded all records
subsequent to the one when patients underwent a
revascularisation.
The choice of diagnoses was guided primarily by
the desire to be consistent with previous papers.21 22
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However, we have also responded to criticism of some earlier
papers by including chest pain (which, as with the other
diagnoses, is analysed separately). This is because it has been
argued that there is a systematic gender bias, in part explained
by the tendency for presentation to be ‘‘atypical’’, that leads to
underdiagnosis of chest pain as being of cardiac origin in
women.8 We do, however, recognise that this is a heterogeneous
population, many of whom will not have cardiovascular disease.
Intervention was defined as the presence of codes for either
percutaneous coronary intervention (ICD-9-CM code 36.0X) or
coronary artery bypass (code 36.1X–36.2) in one of the six
procedure fields of the discharge form.
An initial analysis tabulated the frequencies of each primary
diagnosis, age group ((40, 41–50, 51–60, 61–70, 71–80 and
>81) and secondary diagnosis. As noted above, for 2000 and
2002, the 3M APR-DRG severity of illness (reflecting expected
resource use) and risk of mortality were included. The next step
was to calculate, for each variable, the percentage, for both men
and women, who had been surgically treated.
When there was an association between gender and
revascularisation, bivariate analysis was used to estimate the
corresponding male–female odds ratios, with 95% confidence
intervals, for being treated.
To reduce the influence of potential confounders adjustment
was made for age group, secondary diagnosis of congestive heart
failure (code 428.X) and diabetes mellitus (code 250.XX), which,
from the literature, emerged as the quantifiable factors most
likely to influence treatment decisions. For cases from 2000 and
2002, we were able to generate two models for each diagnosis,
each containing a different variable derived from the APR-DRG
system. These are severity of illness and risk of mortality. As
they are reasonably closely correlated with each other, it was
not thought appropriate to use them both in the same model.
Given the likely inter-relationships between potential expla-
natory variables, multiple logistic regression was used to
determine the odds of undergoing revascularisation after
adjustment for significant covariates, identifying the most
parsimonious model. Thus, the regression used backward
elimination. The initial model included all variables and those
with the highest p values were eliminated at each step until
only those that were significant remained.
The two datasets (with and without APR-DRG data) were
independently analysed.
Data management was performed using Access 2003 whereas
all the statistical procedures were carried out using EpiInfo
V3.3.2 and STATA V8.0.
RESULTS
A total of 77 974 cases fulfilled the inclusion criteria, equally
distributed throughout the study period with a mean of 19 493
cases recorded each year (standard deviation (SD) 417), and
women constituted around 32% each year. Over the whole
study period 80.5% of patients were admitted only once,
whereas readmissions accounted for 19.5% of cases.
The distribution of key variables within the cases meeting the
inclusion criteria is shown in tables 1 and 2, with the numbers
in parenthesis representing the percentages of patients under-
going surgical procedures. The length of stay variable, in the
lowest rows, shows the mean of the hospitalisation days, for
each diagnosis, and the corresponding SD.
Female patients were, on average, older than male patients,
respectively 71.4 (SD 12.5) and 64.2 (SD 12.0). Among those
undergoing surgery, men had a mean age of 62.6 (SD 10.2) and
women of 67.7 (SD 9.41) (a difference of 5.1 years; p,0.001),
whereas among all those hospitalised who did not have
revascularisation the figures were respectively 64.9 (SD 12.7)
and 72.2 (SD 12.9) years old (a difference of 7.3 years; p,0.001).
There was an upward trend over time in the percentage of
patients undergoing interventions, especially among those with
diagnoses of angina or myocardial infarction, in which opera-
tion rates more than doubled, increasing respectively from
14.7% in 1999 to 32.3% in 2002 for men and from 7.2% to 17.1%
for women in the same period.
Table 3 shows the crude and adjusted odds ratios (ORs) for
revascularisation procedures among men compared with
women, according to potential explanatory variables. Crude
analysis demonstrated that, for all diagnoses combined, being
male is an important discriminating factor in whether or not
one undergoes revascularisation (OR 2.11, 95% CI 2.04 to 2.19,
p,0.001) (table 4). Broadly comparable findings were obtained
within each diagnostic category: myocardial infarction, OR 2.09
(95% CI 1.96 to 2.23); angina, OR 1.75 (95% CI 1.61 to 1.90);
chronic ischaemia, OR 2.14 (95% 2.01 to 2.28); and chest pain,
OR 3.95 (CI 1.52 to 10.24) (table 3).
In all cases, the gap narrows when adjusted for age, but
remains highly significant for all diagnostic categories.
Adjustment for the presence of heart failure or diabetes makes
a relatively small difference. In the subset of data with
additional information on severity, adjustment again makes
relatively little difference.
Table 4 shows the fully adjusted model, before and after
backward elimination of variables starting with age group and
presence or absence of diabetes or heart failure, plus, for 2000
and 2002, the two severity scores. In the initial analyses, using
all 4 years of data, all three variables were retained, except for
chest pain (which had the fewest numbers and the least
likelihood of co-morbidity), in which they were all eliminated.
In the restricted dataset from 2000 and 2002, among those with
myocardial infarctions the two final models retained only age
and severity or age and risk of mortality, suggesting that the
presence of heart failure or diabetes as a factor that would
reduce the probability of intervention is viewed similarly in men
and women. In contrast, heart failure (and diabetes for those
with angina after adjustment for mortality risk) do seem to
have a different meaning in men and women with angina or
chronic ischaemia. Chest pain does not seem to be influenced by
any of the studied variables, although this is likely to reflect
both the low numbers of cases, with some age groups
containing no patients, and the low rate of co-morbidity.
Comparing the crude male–female ORs (table 3) with those
in the fully adjusted models (table 4), it can be seen that, with
the exception of the small number of patients with a diagnosis
of chest pain, inclusion of all significant correlates reduces the
gender gap (myocardial infarction 2.09 to 1.33; angina 1.75 to
1.61; and chronic ischaemia 2.14 to 1.48), but in all cases the
greater probability of intervention in men remains highly
statistically significant. Similar results were obtained using the
subset of 2000 and 2002 data, when additional severity
measures were included.
DISCUSSION
In the early twenty-first century, Italian women remain less
likely than men to undergo surgical procedures for coronary
artery disease. This inequity is consistent with previous research
undertaken in the USA, the UK and elsewhere. However, this
study goes beyond many of the earlier studies by showing that
the disparity persists after taking account of differences in
severity of illness. We believe that this is particularly relevant as
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earlier research has given rise to the term ‘‘Yentl syndrome’’,23
named after the film in which a woman disguises herself as a
man to become a rabbi. It is suggested that ‘‘Once a woman
showed that she was just like a man, by having severe coronary
artery disease …, then she was treated as a man would be’’.
Thus, we would expect that the ORs would narrow markedly
after adjustment for severity. There was some narrowing but,
even after the inclusion of all significant variables, including
sophisticated measures of disease severity, women were still less
likely to undergo revascularisation.
It is beyond the scope of this study, which is based on
administrative data, to explain why these inequities exist.
Authors of previous studies proposed two sets of hypotheses to
explain these gender differences. The first focuses on patient
preferences. This is based on the premise that some women do
not see themselves as candidates for revascularisation because
they do not consider themselves to be at risk of coronary heart
diseases. A study addressing this issue reported that all the
women involved expressed surprise when informed of their
diagnosis. The most obvious consequence of this finding is that,
if a woman does not see herself as being at risk of cardiovascular
disease, she will tend to interpret symptoms as being due to
other reasons.24 It has also been reported that women are more
likely than men to decline a major procedure.20 25
Another factor is that women may present with symptoms
that are ‘‘atypical’’, which has been defined largely on the basis
of studies among men. It has been found that women
experiencing an acute myocardial infarction are more likely
than men simultaneously to experience gastrointestinal symp-
toms such as indigestion,26 while it has also been suggested that
there may be difficulty distinguishing some forms of angina
from breast tenderness secondary to cyclical hormonal changes
in premenopausal women or to hormone replacement therapy
in postmenopausal women.27 Another study concluded that,
while there were no major differences in the language used by
women and men to report pain, women may localise it
differently and may be more likely to report supplementary
symptoms.8 We tried to consider this issue, at least partially, by
including patients initially diagnosed as having chest pain rather
than a specific cardiac cause. Even in this much broader group of
patients, women continue to be less likely to be operated on.
The second group of hypotheses focuses on decisions made by
physicians. There is now clear evidence that the gender of a
patient may influence the response of physicians.10 Writers from
a feminist perspective have argued that this reflects perceptions
of the value that each gender contributes to society, with some
male physicians believing that men contribute more than
women.28 It has also been suggested, as noted above, that bias
may arise from the use of diagnostic criteria developed and
validated on men, which may thus be less sensitive and specific
in women,19 so potentially misleading the diagnostician. For
instance, women presenting with chest pain are less likely to have
a positive exercise test and, among those who do have a positive
exercise test, women are still less likely to have coronary artery
disease.29 In addition, some studies suggest that women have
more complications and benefit less following surgery.20
Unfortunately, it is not possible to test these hypotheses
using these data. This would require other techniques such as
ethnography or decision–analysis methods that could explore
the decision-making processes adopted by patients and physi-
cians. Nor is it possible to eliminate entirely some forms of
artefact. There may also be valid clinical considerations that
were undocumented in the clinical records, but these would
require a prospective study which would be fraught with
methodological and ethical problems. Finally, we cannot
exclude the possibility that relevant co-morbidities and contra-
indications were inadequately documented by medical staff. It
is, however, unlikely that there would be selective differences in
recording by gender.
Our study exhibits both strengths and weaknesses. A major
strength is that retrospective analysis of patients’ records
ensured that clinical practice was not influenced by the research
process, thereby biasing findings, but, on the other hand, our
findings might be subject to the problems known to affect any
study using routine information, such as incompleteness of
clinical coding, data inaccuracies and failure to link episodes to
individuals. Nevertheless, we believe that these risks are
minimised by the presence in each facility of strict quality
control systems monitoring the quality of data collection, albeit
that the diligence with which these processes are undertaken
reflects the need to monitor financial rather than clinical
performance. Although we were able to remove all details of
people who had records of previous revascularisation within the
dataset, we cannot exclude the possibility that a small number
may have undergone treatment either elsewhere or before the
study years. It is, however, difficult to see, given the small
Table 4 Models of the relationship between probability of intervention and gender adjusted for possible confounders
Year Pathology Starting model OR (95% CI) p Value Final model OR (95% CI) p Value
1999–2002 All diagnoses 2.11 (2.04 to 2.19) ,0.001
Myocardial infarction hrtfail+diab+clsage 1.33 (1.24 to 1.43) ,0.001 hrtfail+diab+clsage 1.33 (1.24 to 1.43) ,0.001
Angina 1.61 (1.48 to 1.75) ,0.001 1.61 (1.48 to 1.75) ,0.001
Chronic ischaemia 1.48 (1.39 to 1.58) ,0.001 1.48 (1.39 to 1.58) ,0.001
Chest pain 4.30 (1.65 to 11.23) 0.003 – 3.95 (1.52 to 10.24) 0.002
2000 and 2002 All diagnoses 2.18 (2.06 to 2.29) ,0.001
Myocardial infarction hrtfail+diab+clsage+sevill 1.43 (1.30 to 1.58) ,0.001 clsage+sevill 1.43 (1.30 to 1.58) ,0.001
hrtfail+diab+clsage+riskmort 1.44 (1.31 to 1.59) ,0.001 clsage+riskmort 1.45 (1.31 to 1.59) ,0.001
Angina hrtfail+diab+clsage+sevill 1.55 (1.38 to 1.12) ,0.001 clsage+sevill+hrtfail 1.56 (1.39 to 1.75) ,0.001
hrtfail+diab+clsage+riskmort 1.61 (1.44 to 1.80) ,0.001 hrtfail+diab+clsage+riskmort 1.61 (1.44 to 1.80) ,0.001
Chronic ischaemia hrtfail+diab+clsage+sevill 1.53 (1.39 to 1.69) ,0.001 clsage+hrtfail+sevill 1.54 (1.40 to 1.69) ,0.001
hrtfail+diab+clsage+riskmort 1.52 (1.38 to 1.67) ,0.001 clsage+hrtfail+riskmort 1.53 (1.39 to 1.68) ,0.001
Chest pain hrtfail+diab+clsage+sevill 3.69 (1.24 to 10.69) 0.019 – 3.52 (1.20 to 10.30) 0.022
hrtfail+diab+clsage+riskmort 3.88 (1.31 to 14.47) 0.014 – 3.52 (1.20 to 10.30) 0.022
hrtfail, congestive heart failure; diab, diabetes mellitus; clsage: age group; sevill, severity of illness; riskmort, risk of mortality.
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numbers likely to be involved, how this could materially
affect the results.
A second advantage is the inclusion of procedures in both
public and private hospitals, especially in light of a recent study
from the UK showing how private sector provision exacerbates
social inequalities in access to care.30
A third advantage of our study is the inclusion of two
measures of risk adjustment. In our study, men and women
differ significantly in age. This is to be expected, given that
coronary artery disease presents earlier in men,31 but could
introduce a bias into the results. In calculating the severity of
illness rank, the APR-DRG software takes into account not only
relevant co-morbidities but also the interaction between these
co-morbidities and age or the principal diagnosis.32 This is
particularly useful as this procedure allows a meaningful and
fairer comparison of the two groups.
A disadvantage is that we are able to look only at patients
once they have reached hospital. We cannot exclude the
possibility that women might be disadvantaged further by
failure to refer them for investigation. This is less likely in cases
of myocardial infarction but is certainly possible for angina and
chronic ischaemia.
This study has found a substantial gender disparity in the
probability of undergoing revascularisation among patients with
known cardiovascular disease in a large Italian region. This cannot
be accounted for by documented differences in age or severity of
illness. This is, to our knowledge, the first time that this
phenomenon has been documented in Italy. Furthermore, despite
evidence of disparities from elsewhere, we are unaware of any
significant discussion about this issue in Italy, either among
patient or professional groups. While more research is clearly
needed to understand these observations better, we hope that this
study will at least enable the discussion to begin.
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What is already known on this subject
Previous studies documented gender differences in the likelihood of
being treated surgically for ischaemic heart disease. Many
researchers suggested that women are less likely to be operated
because they usually show a less severe picture. This phenomenon,
known as the Yentl syndrome, implies that, once a woman assumes
certain characteristics associated with men (such as classical
clinical presentation), she will receive the same treatment.
What this study adds
Our results, based on a very large dataset, confirm gender
differences for a number of cardiac-related diagnoses.
Furthermore, we find that inequalities persist after adjustment
for severity of illness and risk of mortality.
Research report
208 J Epidemiol Community Health 2009;63:203–208. doi:10.1136/jech.2008.077537
